Annual Retained Earnings
-$437.41 M
-$59.08 M-15.62%
31 December 2023
Summary:
Galera Therapeutics annual retained earnings is currently -$437.41 million, with the most recent change of -$59.08 million (-15.62%) on 31 December 2023. During the last 3 years, it has fallen by -$201.84 million (-85.68%). GRTX annual retained earnings is now -474.76% below its all-time high of -$76.10 million, reached on 31 December 2017.GRTX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$445.85 M
-$4.06 M-0.92%
30 June 2024
Summary:
Galera Therapeutics quarterly retained earnings is currently -$445.85 million, with the most recent change of -$4.06 million (-0.92%) on 30 June 2024. Over the past year, it has dropped by -$14.03 million (-3.25%). GRTX quarterly retained earnings is now -325.34% below its all-time high of -$104.82 million, reached on 31 December 2018.GRTX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GRTX Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -15.6% | -3.3% |
| 3 y3 years | -85.7% | -49.0% |
| 5 y5 years | -317.3% | -208.2% |
GRTX Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -85.7% | at low | -49.0% | at low |
| 5 y | 5 years | -317.3% | at low | -208.2% | at low |
| alltime | all time | -474.8% | at low | -325.3% | at low |
Galera Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| June 2024 | - | -$445.85 M(+0.9%) |
| Mar 2024 | - | -$441.79 M(+1.0%) |
| Dec 2023 | -$437.41 M(+15.6%) | -$437.41 M(+1.3%) |
| Sept 2023 | - | -$431.82 M(+3.6%) |
| June 2023 | - | -$416.75 M(+5.2%) |
| Mar 2023 | - | -$396.03 M(+4.7%) |
| Dec 2022 | -$378.32 M(+19.7%) | -$378.32 M(+4.5%) |
| Sept 2022 | - | -$362.14 M(+4.6%) |
| June 2022 | - | -$346.10 M(+4.4%) |
| Mar 2022 | - | -$331.55 M(+4.9%) |
| Dec 2021 | -$316.10 M | -$316.10 M(+5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | -$299.30 M(+8.2%) |
| June 2021 | - | -$276.67 M(+8.8%) |
| Mar 2021 | - | -$254.28 M(+7.9%) |
| Dec 2020 | -$235.57 M(+46.0%) | -$235.57 M(+9.3%) |
| Sept 2020 | - | -$215.50 M(+8.6%) |
| June 2020 | - | -$198.42 M(+10.4%) |
| Mar 2020 | - | -$179.77 M(+11.4%) |
| Dec 2019 | -$161.35 M(+53.9%) | -$161.35 M(+11.5%) |
| Sept 2019 | - | -$144.68 M(+11.5%) |
| June 2019 | - | -$129.74 M(+23.8%) |
| Dec 2018 | -$104.82 M(+37.7%) | -$104.82 M |
| Dec 2017 | -$76.10 M | - |
FAQ
- What is Galera Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Galera Therapeutics?
- What is Galera Therapeutics annual retained earnings year-on-year change?
- What is Galera Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Galera Therapeutics?
- What is Galera Therapeutics quarterly retained earnings year-on-year change?
What is Galera Therapeutics annual retained earnings?
The current annual retained earnings of GRTX is -$437.41 M
What is the all time high annual retained earnings for Galera Therapeutics?
Galera Therapeutics all-time high annual retained earnings is -$76.10 M
What is Galera Therapeutics annual retained earnings year-on-year change?
Over the past year, GRTX annual retained earnings has changed by -$59.08 M (-15.62%)
What is Galera Therapeutics quarterly retained earnings?
The current quarterly retained earnings of GRTX is -$445.85 M
What is the all time high quarterly retained earnings for Galera Therapeutics?
Galera Therapeutics all-time high quarterly retained earnings is -$104.82 M
What is Galera Therapeutics quarterly retained earnings year-on-year change?
Over the past year, GRTX quarterly retained earnings has changed by -$14.03 M (-3.25%)